Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119681) titled 'Observational study on the combination of fruquintinib and standard chemotherapy in the treatment of advanced gastric cancer' on March 2.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Gastric cancer or adenocarcinoma of the gastroesophageal junction
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-01
Target Sample Size: Observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297854
Published by HT Digital Content Services with permission fro...